AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8256902 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (7.5 mg cumulative dose)
Number of subjects: 10
Study 8256902 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (15.0 mg cumulative dose)
Number of subjects: 10
Study 8256902 — intervention group
Group type: COMPARATOR
Intervention: MDI albuterol (100 puffs, 9 mg)
Number of subjects: 10
Study 3899418 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide (2.5 mg/day)
Number of subjects: 31
Study 3899418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 30772533 — intervention group
Group type: EXPERIMENTAL
Intervention: Triggers for atrial fibrillation (AF)
Number of subjects: 1295
Study 29587770 — intervention group
Group type: EXPERIMENTAL
Intervention: Powdered Nigella sativa
Number of subjects: 40
Study 29587770 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 27094555 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching
Number of subjects: 0
Study 27094555 — intervention group
Group type: EXPERIMENTAL
Intervention: Coupons
Number of subjects: 0
Study 27094555 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruits and Vegetables
Number of subjects: 0
Study 27094555 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Fat
Number of subjects: 0
Study 24315979 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 80
Study 22544004 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label olanzapine treatment (2.5 or 5 mg/d, increased up to 20 mg/d in study 1 or 15 mg/d in study 2)
Number of subjects: 472
Study 22544004 — intervention group
Group type: COMPARATOR
Intervention: Open-label olanzapine treatment after placebo during the acute phase
Number of subjects: 472
Study 22544004 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label olanzapine treatment after olanzapine during the acute phase
Number of subjects: 472
Study 20416995 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine supplementation
Number of subjects: 30
Study 20416995 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 18922335 — intervention group
Group type: EXPERIMENTAL
Intervention: Pillar palate implants
Number of subjects: 100
Study 18922335 — intervention group
Group type: COMPARATOR
Intervention: Sham placebo
Number of subjects: 100
Study 15014218 — intervention group
Group type: EXPERIMENTAL
Intervention: LocaLisa non‐fluoroscopic catheter navigation system
Number of subjects: 21
Study 15014218 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopic guidance alone (Control)
Number of subjects: 21
Study 12458116 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined antiemetic strategy including nursing intervention program (increased access to support and increased information) and antiemetics based on high‐dose metoclopramide and dexamethasone
Number of subjects: 162
Study 12458116 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron plus dexamethasone
Number of subjects: 162
Study 12458116 — intervention group
Group type: COMPARATOR
Intervention: Standard antiemetic treatment during the 1980s
Number of subjects: 162
Study 9654537 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking during active labor
Number of subjects: 536
Study 9654537 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no walking)
Number of subjects: 536
Study 8081005 — intervention group
Group type: EXPERIMENTAL
Intervention: CY-TBI (60 mg/kg cyclophosphamide on each of 2 successive days followed by 6 fractions of total body irradiation each of 2.0 Gy)
Number of subjects: 142
Study 8081005 — intervention group
Group type: COMPARATOR
Intervention: BU-CY (16 mg/kg busulfan over 4 days followed by 60 mg/kg cyclophosphamide on each of 2 successive days)
Number of subjects: 142
Study 2526824 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin 10 mg/day
Number of subjects: 38
Study 2526824 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin 25 mg/day
Number of subjects: 38
Study 2526824 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin 50 mg/day
Number of subjects: 38
Study 2526824 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin 75 mg/day
Number of subjects: 38
Study 2526824 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 176881 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol infusion
Number of subjects: 0
Study 176881 — intervention group
Group type: COMPARATOR
Intervention: Glucose infusion
Number of subjects: 0
Study 28407722 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced hypothermia at 33°C
Number of subjects: 0
Study 28407722 — intervention group
Group type: COMPARATOR
Intervention: Control group at 36°C
Number of subjects: 0
Study 26716587 — intervention group
Group type: EXPERIMENTAL
Intervention: Transulnar access (TUA)
Number of subjects: 2532
Study 26716587 — intervention group
Group type: COMPARATOR
Intervention: Transradial access (TRA)
Number of subjects: 2532
Study 24684808 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented robot-assisted arm-hand training
Number of subjects: 22
Study 24684808 — intervention group
Group type: COMPARATOR
Intervention: Task-oriented non-robotic arm-hand training (Control)
Number of subjects: 22
Study 22674157 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar epidural morphine
Number of subjects: 55
Study 22674157 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural morphine
Number of subjects: 55
Study 19744087 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance athletes
Number of subjects: 96
Study 19744087 — intervention group
Group type: COMPARATOR
Intervention: Hypertensive patients
Number of subjects: 96
Study 19744087 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 96
Study 17700400 — intervention group
Group type: EXPERIMENTAL
Intervention: RAA pacing during DDD
Number of subjects: 42
Study 17700400 — intervention group
Group type: EXPERIMENTAL
Intervention: IAS pacing during DDD
Number of subjects: 42
Study 17700400 — intervention group
Group type: COMPARATOR
Intervention: IAS pacing
Number of subjects: 42
Study 17700400 — intervention group
Group type: COMPARATOR
Intervention: RAA pacing
Number of subjects: 42
Study 16282841 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxcarbazepine
Number of subjects: 48
Study 16282841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 12139223 — intervention group
Group type: EXPERIMENTAL
Intervention: Halofantrine (500 mg)
Number of subjects: 13
Study 12139223 — intervention group
Group type: COMPARATOR
Intervention: Co-artemether (80/480 mg)
Number of subjects: 13
Study 10334254 — intervention group
Group type: COMPARATOR
Intervention: Continuous running suture (CRS) technique
Number of subjects: 390
Study 10334254 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous double-loop closure (CDLC) technique
Number of subjects: 390
Study 8588061 — intervention group
Group type: EXPERIMENTAL
Intervention: 75-100 mg/day amitriptyline (n=16)
Number of subjects: 26
Study 8588061 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day amineptine (n=10)
Number of subjects: 26
Study 8588061 — intervention group
Group type: COMPARATOR
Intervention: Baseline rCBF values of depressed patients
Number of subjects: 26
Study 8588061 — intervention group
Group type: COMPARATOR
Intervention: Chronic treatment with classic tricyclic antidepressants
Number of subjects: 26
Study 8588061 — intervention group
Group type: COMPARATOR
Intervention: Dopaminergic drugs
Number of subjects: 26
Study 1760779 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing with denture paste (Dentu-Creme)
Number of subjects: 18
Study 1760779 — intervention group
Group type: EXPERIMENTAL
Intervention: Soaking in Efferdent
Number of subjects: 18
Study 1760779 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing followed by soaking in Efferdent
Number of subjects: 18
Study 1760779 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 18
Study 6817270 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% glycopyrrolate roll-on lotion and cream
Number of subjects: 22
Study 6817270 — intervention group
Group type: COMPARATOR
Intervention: Topical scopolamine (solution and cream)
Number of subjects: 22
Study 6817270 — intervention group
Group type: COMPARATOR
Intervention: Glycopyrrolate (roll-on lotion, solution, and cream)
Number of subjects: 22
Study 31468214 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid-restrictive vasopressor-dominated hemodynamic support (FRV) with norepinephrine concentration of 0.065±0.020 μg/kg/min
Number of subjects: 44
Study 31468214 — intervention group
Group type: COMPARATOR
Intervention: Liberal fluid administration (LFA) with fluid administration of 5.1±2.2 ml/kg/h
Number of subjects: 44
Study 31617141 — intervention group
Group type: EXPERIMENTAL
Intervention: Stiripentol as adjunctive therapy
Number of subjects: 0
Study 31617141 — intervention group
Group type: EXPERIMENTAL
Intervention: Stiripentol with clobazam and valproate
Number of subjects: 0
Study 28831954 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet D:E‐1·09
Number of subjects: 90
Study 28831954 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet D:E‐2·05
Number of subjects: 90
Study 28831954 — intervention group
Group type: COMPARATOR
Intervention: Diet D:E‐0·68
Number of subjects: 90
Study 26391775 — intervention group
Group type: EXPERIMENTAL
Intervention: Dignity Therapy
Number of subjects: 90
Study 26391775 — intervention group
Group type: COMPARATOR
Intervention: Supportive Attention
Number of subjects: 90
Study 23235272 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefrontal transcranial direct current stimulation (tDCS)
Number of subjects: 19
Study 23235272 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 19
Study 22244642 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper rotary instruments
Number of subjects: 50
Study 22244642 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adjusting file (SAF) system
Number of subjects: 50
Study 22244642 — intervention group
Group type: COMPARATOR
Intervention: Control group (ProTaper rotary instruments)
Number of subjects: 50
Study 20124283 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative multimedia information (short film depicting in-hospital journey)
Number of subjects: 110
Study 20124283 — intervention group
Group type: COMPARATOR
Intervention: Control group (no multimedia information)
Number of subjects: 110
Study 16533861 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0
Study 16533861 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 0
Study 16533861 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovered depressed subjects
Number of subjects: 0
Study 16313817 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel plus carboplatin
Number of subjects: 125
Study 16313817 — intervention group
Group type: COMPARATOR
Intervention: Three weeks paclitaxel plus carboplatin
Number of subjects: 125
Study 12399344 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits by community nurse at one and four weeks after discharge and preventive general practitioner care
Number of subjects: 177
Study 12399344 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits by community nurse
Number of subjects: 177
Study 12399344 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge and satisfaction measures
Number of subjects: 177
Study 12399344 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 177
Study 12399344 — intervention group
Group type: COMPARATOR
Intervention: General practitioner involvement
Number of subjects: 177
Study 10660174 — intervention group
Group type: EXPERIMENTAL
Intervention: Toronto SPV stentless bioprosthesis
Number of subjects: 40
Study 10660174 — intervention group
Group type: COMPARATOR
Intervention: Carpentier Edwards SAV (CE) bioprosthesis
Number of subjects: 40
Study 7775623 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estrogen (Estraderm‐TTS 100)
Number of subjects: 9
Study 7775623 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estrogen (Premarin, 1.25 mg)
Number of subjects: 9
Study 7775623 — intervention group
Group type: EXPERIMENTAL
Intervention: Both oral and transdermal estrogen
Number of subjects: 9
Study 2310655 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g day-1 acetylsalicylic acid
Number of subjects: 11
Study 2310655 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g day-1 paracetamol
Number of subjects: 11
Study 2310655 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g day-1 acetylsalicylic acid and 1.5 g day-1 paracetamol (combination)
Number of subjects: 11
Study 2310655 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g day-1 acetylsalicylic acid (separated by washout phases)
Number of subjects: 11
Study 2310655 — intervention group
Group type: EXPERIMENTAL
Intervention: All four drug schedules
Number of subjects: 11
Study 6184562 — intervention group
Group type: EXPERIMENTAL
Intervention: VER (80 mg t.i.d.)
Number of subjects: 12
Study 6184562 — intervention group
Group type: EXPERIMENTAL
Intervention: NIF (10 mg t.i.d.)
Number of subjects: 12
Study 6184562 — intervention group
Group type: EXPERIMENTAL
Intervention: VER (160 mg t.i.d.)
Number of subjects: 12
Study 6184562 — intervention group
Group type: EXPERIMENTAL
Intervention: VER (80 mg t.i.d.) and NIF (10 mg t.i.d.)
Number of subjects: 12
Study 31541880 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulated distributions of speed and direction tuning widths in convolutional networks for visual odometry and gesture recognition tasks.
Number of subjects: 0
Study 31541880 — intervention group
Group type: EXPERIMENTAL
Intervention: Random linear mixtures of the responses in convolutional networks.
Number of subjects: 0
Study 31541880 — intervention group
Group type: EXPERIMENTAL
Intervention: Responses randomized while maintaining representational dissimilarity.
Number of subjects: 0
Study 30691510 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxemia or hypoxemia exposure during the first 37 hours after ROSC
Number of subjects: 869
Study 30691510 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak serum Tau levels at 48 or 72 hours after ROSC
Number of subjects: 869
Study 28840263 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop insulin delivery
Number of subjects: 20
Study 28840263 — intervention group
Group type: COMPARATOR
Intervention: Open-loop insulin delivery
Number of subjects: 20
Study 25901546 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized albuterol
Number of subjects: 25
Study 23836575 — intervention group
Group type: EXPERIMENTAL
Intervention: Waterless hand sanitizer intervention
Number of subjects: 8733
Study 23836575 — intervention group
Group type: EXPERIMENTAL
Intervention: Handwashing with soap intervention
Number of subjects: 8733
Study 23836575 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 8733
Study 17529914 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Dental Anaesthesia (EDA)
Number of subjects: 60
Study 17529914 — intervention group
Group type: COMPARATOR
Intervention: Control (regional anaesthesia)
Number of subjects: 60
Study 15296021 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient counseling with postdischarge telephone contacts at 7, 21 and 42 days after discharge
Number of subjects: 106
Study 15296021 — intervention group
Group type: COMPARATOR
Intervention: Public health nurse‐mediated behaviorally oriented inpatient counseling (control group)
Number of subjects: 106
Study 11014673 — intervention group
Group type: EXPERIMENTAL
Intervention: Myopic group (children with myopia)
Number of subjects: 168
Study 11014673 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmyopic group (children without myopia)
Number of subjects: 168
Study 11014673 — intervention group
Group type: COMPARATOR
Intervention: Nearwork scores from diaries
Number of subjects: 168
Study 9110517 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated mental health and substance abuse treatment program
Number of subjects: 0
Study 9110517 — intervention group
Group type: COMPARATOR
Intervention: Standard psychiatric hospital treatment
Number of subjects: 0
Study 8408725 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% triclosan mouthrinse
Number of subjects: 30
Study 8408725 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% triclosan mouthrinse
Number of subjects: 30
Study 8408725 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% triclosan mouthrinse
Number of subjects: 30
Study 8408725 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% triclosan mouthrinse
Number of subjects: 30
Study 8408725 — intervention group
Group type: COMPARATOR
Intervention: Control group (minus-active control)
Number of subjects: 30
Study 3317338 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 28
Study 3317338 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 28
Study 3317338 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 28
Study 30430201 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-running, moderate-intensity exercise (60-70%), two times/week
Number of subjects: 42
Study 30430201 — intervention group
Group type: COMPARATOR
Intervention: No additional treatment other than the prescribed medication (Control)
Number of subjects: 42
Study 28399981 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors plus insulin
Number of subjects: 178
Study 28399981 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus insulin
Number of subjects: 178
Study 26370528 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective group (Group P) - tidal volume of 6 mL/kg, FiO2 of 80%, PEEP of 5 cm H2O
Number of subjects: 60
Study 26370528 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (Group C) - tidal volume of 8 mL/kg, FiO2 of 100%
Number of subjects: 60
Study 23381490 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck Disability Index (NDI)
Number of subjects: 50
Study 23381490 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-12 Physical Component Scale (SF-12 PCS)
Number of subjects: 50
Study 23381490 — intervention group
Group type: EXPERIMENTAL
Intervention: EuroQol-5D (EQ-5D)
Number of subjects: 50
Study 23381490 — intervention group
Group type: EXPERIMENTAL
Intervention: Zung Self-Rating Depression Scale
Number of subjects: 50
Study 20824894 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron 60 mg/day for 26 weeks
Number of subjects: 260
Study 20824894 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 26 weeks
Number of subjects: 260
Study 19154568 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 111
Study 19154568 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine
Number of subjects: 111
Study 16648499 — intervention group
Group type: EXPERIMENTAL
Intervention: 78 Gy radiotherapy
Number of subjects: 669
Study 16648499 — intervention group
Group type: COMPARATOR
Intervention: 68 Gy radiotherapy
Number of subjects: 669
Study 15624283 — intervention group
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA) 1.2 g/d
Number of subjects: 20
Study 15624283 — intervention group
Group type: COMPARATOR
Intervention: NCEP‐II diet alone
Number of subjects: 20
Study 15624283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 15624283 — intervention group
Group type: COMPARATOR
Intervention: Washout phase
Number of subjects: 20
Study 15624283 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 20
Study 11577791 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Number of subjects: 100
Study 11577791 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 800 microg/day
Number of subjects: 100
Study 11577791 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone 1200 microg/day
Number of subjects: 100
Study 11577791 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose inhaled corticosteroids
Number of subjects: 100
Study 11577791 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 9267685 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole administered as tablets after fasting
Number of subjects: 0
Study 9267685 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole administered as tablets with food
Number of subjects: 0
Study 9267685 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole administered as tablets with Maalox (antacid)
Number of subjects: 0
Study 9267685 — intervention group
Group type: COMPARATOR
Intervention: Sertindole administered as solution
Number of subjects: 0
Study 9267685 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole administered as tablets under fasting conditions
Number of subjects: 0
Study 7905226 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticholinergic medication
Number of subjects: 27
Study 7905226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 7905226 — intervention group
Group type: COMPARATOR
Intervention: No antiparkinsonian drug
Number of subjects: 27
Study 3573764 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-mm portacaval H-grafts
Number of subjects: 29
Study 3573764 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-mm portacaval H-grafts
Number of subjects: 29
Study 3573764 — intervention group
Group type: EXPERIMENTAL
Intervention: Shunts larger than 10 mm
Number of subjects: 29
Study 28627275 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week mixed-modality supervised exercise program (4 times a week, twice a day)
Number of subjects: 17
Study 28627275 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 17
Study 27357530 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-Albumin group (fresh autologous cancellous bone enhanced with albumin-coated allograft)
Number of subjects: 0
Study 27357530 — intervention group
Group type: COMPARATOR
Intervention: Control group (autologous bone alone)
Number of subjects: 0
Study 27357530 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-Albumin group
Number of subjects: 0
Study 24417762 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular implant‐retained overdentures
Number of subjects: 116
Study 24417762 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant‐supported fixed partial dentures (FPDs)
Number of subjects: 116
Study 24417762 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional complete dentures
Number of subjects: 116